Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
DEFM14A

Definitive proxy statement relating to merger or acquisition

Mergers & Acquisitions
EFFECT

EFFECT

Other
EFFECT

EFFECT

Other
EFFECT

EFFECT

Other
EFFECT

EFFECT

Other
EFFECT

EFFECT

Other
NT 10-K

Notification that form 10-K will be submitted late

Annual Filings
NT 10-K

Notification that form 10-K will be submitted late

Annual Filings
NT 10-K

Notification that form 10-K will be submitted late

Annual Filings